IRCT20200623047902N27Not yet recruitingUnknown
Bioequivalence study of Metformin 500mg tablet manufactured by Ronak Pharm versus originator brand in healthy volunteers in the fasted and fed conditions
Ronak Pharm company0 sites36 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 36
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 55 years (—)
- Sex
- All
Inclusion Criteria
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
Exclusion Criteria
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcohol and drug addiction
- •History of allergy to Metformin
Investigators
Similar Trials
Completed
Not Applicable
Bio equivalence study of metformin 500 mgIRCT20200513047423N1Sana Med24
Recruiting
Unknown
Bioequivalence study of metformin 1000 mg tabletsIRCT20230222057495N14Jalinous Pharmaceutical Company24
Recruiting
Not Applicable
Bioequivalence study of Metformin ER 500 mg tabletIRCT20220111053692N3Saponine Pharmaceutical Company24
Not yet recruiting
Not Applicable
Bioequivalance study of Metformin 1000 mg TabletsBioequivalance Metformin 1000 mg.IRCT20200513047423N8Sana Med24
Not yet recruiting
Unknown
In-vivo Bioequivalence Study of Metformin 500 mg FC. Tablets of The Test Drug ( Sajjad Darou, Iran)IRCT20200105046010N106Sajad darou shargh24